Skip to main content
Premium Trial:

Request an Annual Quote

IBM, Proteome Systems Pen Proteomics Alliance

NEW YORK, Nov. 20 — IBM and Australian proteomics firm Proteome Systems have formed an international proteomics-analysis alliance, the companies said on Tuesday.


Under the agreement, IBM, based in Armonk, NY, will supply the IT infrastructure for Proteome Systems' new discovery platform and provide hardware, software, support, and education and marketing programs for the company's ongoing research.


Proteome Systems, based in Sydney, is currently developing a new version of its proteomics discovery platform, to be called ProteomIQ(a), and plans its launch for some time next year.


The partnership was originally reported in the Nov. 12 issue of ProteoMonitor.


"There's a lot of work that has gone into making sure all of the different elements of the platform integrate, and we haven't established this on any platform other than the IBM platform and we probably won't," Proteome Systems CEO Keith Williams told ProteoMonitor.


For the company's in-house research IBM will provide its next-generation UNIX server, the IBM eServer(b) p690, or "Regatta," which includes two processors that top one-gigahertz capability and new capability to maintain function during major system failures.


Proteome Systems will also have access to IBM's worldwide marketing and technical support programs.


This is the latest in a series of proteomics-based partnerships for IBM's Life Sciences division. In the last year, the division also struck deals with MDS-Proteomics and Structural Bioinformatics.

The Scan

Unique Germline Variants Found Among Black Prostate Cancer Patients

Through an exome sequencing study appearing in JCO Precision Oncology, researchers have found unique pathogenic or likely pathogenic variants within a cohort of Black prostate cancer patients.

Analysis of Endogenous Parvoviral Elements Found Within Animal Genomes

Researchers at PLOS Biology have examined the coevolution of endogenous parvoviral elements and animal genomes to gain insight into using the viruses as gene therapy vectors.

Saliva Testing Can Reveal Mosaic CNVs Important in Intellectual Disability

An Australian team has compared the yield of chromosomal microarray testing of both blood and saliva samples for syndromic intellectual disability in the European Journal of Human Genetics.

Octopus Brain Complexity Linked to MicroRNA Expansions

Investigators saw microRNA gene expansions coinciding with complex brains when they analyzed certain cephalopod transcriptomes, as they report in Science Advances.